Topics

Companies Related to "backed study investigating mammography inching toward kickoff date" [Most Relevant Company Matches] RSS

11:59 EST 10th December 2019 | BioPortfolio

Here are the most relevant search results for "backed study investigating mammography inching toward kickoff date" found in our extensive corporate database of over 50,000 company records.

Showing "backed study investigating mammography inching toward kickoff date" Companies 1–25 of 1,600+

Relevant

U-Systems, Inc.

U-Systems is the leader in developing dedicated breast ultrasound systems. For more information about the company, please visit our website at http://www.u-systems.com. For further information about the SOMO·INSIGHT clinical study, visit www.somoinsightstudy.org. The U-Systems somo•v Automated Breast Ultrasound System (ABUS) is currently cleared un...


BioLucent

The company is dedicated to improving the mammography experience with the goal of increasing the number of women who benefit from regular, recommended screening mammograms. Dr. Gail Lebovic, now lead surgeon at Baylor Breast Care Specialists of North Texas, invented MammoPad® with the hope that if mammography were more comfortable, it would help to increase the compliance rate — potentially sav...

Iconic Therapeutics, Inc.

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and cancer. The company’s lead product candidate, ICON-1, is a novel fusion protein designed to address the basis of vision loss in AMD. By targeting inflammation and a...


Solis Mammography

Celebrating over three decades in breast imaging, Solis Mammography is headquartered in Addison, Texas. Solis currently operates 50 centers across seven major markets – North Texas; Houston, Texas; Phoenix, Arizona; Columbus, Ohio; Greensboro, North Carolina; Philadelphia, Pennsylvania, and, through its acquisition of Washington Radiology (WR), the D....

U-Systems

U-Systems is the leader in developing automated breast ultrasound systems and the sponsor of the SOMO•INSIGHT multi-center study that will enroll up to 20,000 women at clinical study sites in the United States to determine the sensitivity of mammography and somo•v Automated Breast Ultrasound Systems (ABUS) together, compared to mammography alone for ...

CNS Network

CNS Network, Inc is dedicated to furthering the knowledge and application of psychiatric medications. We perform trials investigating the efficacy of medications for depression, schizophrenia, bipolar disorder, anxiety and Alzheimer's disease. CNS Network, Inc offers a professional staff including physicians, psychologist, nurses, study coordinators and master level clinicians committed to conduct...

Americas Amigas

Americas Amigas, a non-profit organization, was founded in 2009 by Barbara Sobel, Chella Safra, Maria Antonia Civitia, Andrea Pereira, Francisca de Paula Harley, Eric Street, Sergio Simon, Carlos Alberto Vieira, Ida Sztamfater, Laura Gould, Marcelo Secaf, and Richard Aldrich Jr. Headquartered in Sāo Paulo, Brazil, they have, in a short period of time, m...

DOBI Medical International, Inc.

DOBI Medical International, headquartered in Mahwah, NJ, is a technology-based medical device company that is developing a unique and potentially lifesaving means for the improved diagnosis of cancer through the detection of abnormal vascularization changes associated with tumors.Our first application of this technology has been to develop an adjunctive tool to mammography - a key diagnostic imagi...

Mammography Reporting System, Inc. (MRS)

Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose...

Mirabel Medical, Inc

Mirabel Medical is developing innovative solutions for the non-invasive, accurate and cost-effective detection of breast cancer, based on a powerful and patented new technology, Electrical Impedance Scanning (EIS).In 1999, an earlier version of the TS2000 underwent clinical trials in the United States, Europe and Israel and received FDA approval as an adjunct to mammography. The T-Scan™ 2000ED i...

ZenBio, Inc.

ZenBio, Inc., a privately held biotechnology company, is a leading provider of research tools for the study of human metabolic disease. Founded in 1995, the company performs contract research for major pharmaceutical and biotechnology companies around the world. ZenBio pioneered tissue engineering with adult adipose-derived stem cells and is currently inve...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Bioscience Association Manitoba

Read the study here: https://www.biomb.ca/news/reports/561/2019-bam-industry-profile-study

Iconic Therapeutics

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and cancer. The company’s lead product candidate, ICON-1, is a novel fusion protein designed to address the basis of vision loss in AMD. By targeting inflammation and a...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions that have been used in more than 400 clinical trials by over 100 biopharmaceutical clients. Its proven LogPad® System and versatile SitePad® Tablet deliver the voice of the patient, in 88 languages, from homes and sites in 65 countries around the world. By capt...

Up To Date Laundry, Inc.

Located in Baltimore, Maryland, Up To Date Laundry is one of the largest healthcare laundries on the east coast, processing close to 62 million pounds of healthcare linen each year. It offers rental and customer-owned-goods processing, as well as full exchange cart programs for hospitals in the Mid-Atlantic region. Its non-acute division, Up To Date Health...

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

BvcaEuropean Private Equity

The London markets and private equity-backed IPOs', prepared for the BVCA and the London Stock Exchange by Oxera, examines certain aspects relevant to assessing the attractiveness of the London markets for private equity-backed IPOs. The report specifically looks at the proportion of private equity-backed companies that float on the London markets, their after-market

Probably Relevant

Outpatient Diagnostic Center of Huntsville (“ODC Huntsville”)

Outpatient Diagnostic Center serves the surrounding counties with comprehensive, quality medical imaging services, while helping to control out-of-pocket healthcare costs and delivering a patient experience that puts the care back in healthcare. The Huntsville office (115 St Clair Avenue SE) provides a full complement of imaging services, including MRI, CT...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Synergos, Inc.

Welcome to SYNERGOS, Inc., a Contract Research Organization that provides comprehensive clinical research and development services, from study design through regulatory submission. Founded in 1991, we have substantial experience in pharmaceuticals, medical devices, and biotechnology product development, with significant expertise in numerous therapeutic and diagnostic areas. To date, we have man...

Sigmascreening

Sigmascreening, founded in 2009, is an Amsterdam based MedTech company focusing on the development of new innovative products in the area of digital mammography and breast cancer

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.


More From BioPortfolio on "backed study investigating mammography inching toward kickoff date"

Quick Search

Corporate Database Quicklinks